See also this year's filing and all EDGAR filings for this company.
PDF Report 0001535955_2023_Lipocine_Inc.pdf
Logs
Graph
Absolute values for 0001535955, Lipocine Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 34,135,080 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 131,589 |
| 3 | remainder_Assets | 3,276,253 |
| 4 | LiabilitiesCurrent | 1,678,126 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 229,856 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,062,487 |
| 9 | ResearchAndDevelopmentExpense | 8,556,888 |
| 10 | remainder_Expenses | 681 |
| 11 | remainder_Revenues | 500,000 |
| 12 | remainder_NetIncome | 1,361,420 |
| 13 | remainder_ComprehensiveNetIncome | -2,305 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,542,922 |
| 1 | Liabilities | 1,907,982 |
| 2 | Expenses | 12,620,056 |
| 3 | Revenues | 500,000 |
| 4 | StockholdersEquity | 35,634,940 |
| 5 | NetIncome | -10,758,636 |
| 6 | ComprehensiveNetIncome | -10,759,788 |
| 7 | BaseVar | 26,967,342 |
| 8 | EconomicCapitalRatio | 2.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
